The Centre for Biochemical Sensors (CBS) is a partnership between several research groups focused on specific aspects of healthcare at Imperial College London and a small group of international photonics laboratories and medical instruments companies. CBS provides a pathway to address global healthcare issues involving open innovation in partnership with clinicans and companies of international importance. Founded upon the Imperial’s world-leading facilities and expertise in biophotonics and medical devices, CAS is housed within the Department of Chemical Engineering although its activities involve many academic researchers over the world.
Our research interests are primarily focused on the development and validation of biophotonic medical devices and sensors for application in clinical or point-of-care diagnostics. We conduct research to create novel materials and photonics devices that can reversibly sense biomarkers in biological samples at nano/micromolar sensitivity. The applications of these biophotonic technologies are in wearable devices, minimally-invasive sensors with subcutaneous probes, and implantable chips for prolonged biomarker monitoring.